CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}

Properties & Pathways Acquires Logan Central Medical Centre for $12.19 Million

Jess Freeman • 09/06/2023

Logan-Central-Medical-Centre

Properties & Pathways has successfully acquired the Logan Central Medical Centre in Queensland from Centuria for $12.19 million, further strengthening Properties & Pathways' portfolio in the healthcare real estate sector.

Logan Central Medical Centre is a well-established medical facility situated on a prime 6,130sqm corner site at the intersection of Logan and Wembley Roads. With its central location and high visibility, the medical centre offers excellent accessibility to the local community.

The property features 10 single-level tenancies, encompassing a total Net Lettable Area (NLA) of 1,850sqm. The centre is anchored by ASX-listed Sonic Healthcare, including IPN Medical Centre, QLD X-Ray, and Sullivan Nicolaides Pathology. Furthermore, the facility provides ample parking with 44 car parks available for visitors and staff.

Mike Walsh and Peter Court of Cushman & Wakefield, along with Simon Quinn and Thomas Thorsen of JLL negotiated the sale on behalf of Centuria.

Mike Walsh, Director, Joint Head of Middle Markets, QLD at Cushman & Wakefield, commented on the evolving nature of healthcare real estate, which has become an attractive asset class for institutional investors.

“The non-cyclical income stream and increasing demand, driven by higher life expectancy and an ageing population in Australia, have made healthcare real estate an appealing investment. Furthermore, substantial government investments and the growth of the private health insurance sector have contributed to the expansion of healthcare expenditure in the country” he said.

The City of Logan LGA is projected to experience significant population growth in the coming years, particularly within the 65+ age group. This demographic trend is expected to be the main driver for increased demand in medical and healthcare services. Properties & Pathways recognizes this opportunity and is well-positioned to cater to the growing needs of the local community.

Peter Court, Director, Joint Head of Middle Markets, QLD at Cushman & Wakefield, said with the acquisition of Logan Central Medical Centre, Properties & Pathways reaffirms its commitment to investing in high-quality healthcare assets and providing exceptional medical facilities to communities across Australia.

“The company looks forward to delivering outstanding services and meeting the healthcare needs of Logan Central and its surrounding areas”.

How can we help?

Get in touch with one of our professionals.

RECENT NEWS

325A Nepean Highway, Frankston VIC_.jpg
Australia’s First Sinopec Petrol Station Sells for $6.415M in Landmark Deal

In a significant milestone for Australia’s fuel retail sector, the country’s first Sinopec-leased petrol station at 325A Nepean Highway, Frankston VIC has sold for $6,415,000, reflecting a sharp yield of 5.81%. 

Jess Freeman • 05/12/2025

26 South Terrace, Fremantle 29.jpg
Silverleaf Investments Acquires Fremantle Timezone Icon for $7.65M

In a strong demonstration of investor confidence in Western Australia’s retail market, Silverleaf Investments has acquired the landmark property at 26 South Terrace, Fremantle for $7,650,000, from Yolk Piazza 21 Pty Ltd, reflecting a sharp sales yield of 5.89%.

Jess Freeman • 04/12/2025

13 Garden Street, South Eveleigh
Cushman & Wakefield Capital Markets Team Wins Centuria's 2025 NSW Office Deal of the Year

Cushman & Wakefield is proud to announce that its NSW Capital Markets team has been awarded Centuria’s 2025 Office Deal of the Year.

Jess Freeman • 03/12/2025

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Privacy & Cookies.
MORE OPTIONS
AGREE AND CLOSE
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS